Kusiyanisa Kuvhara uye Kuzvidzora Mafungiro Emapfupa NeFV1 / FVC
Mukuongorora nekurapa zvirwere zvemapapu zvinokanganisa zvakadai sechirwere obstructive pulmonary disease (COPD), vanachiremba vanogara vachishandisa miedzo yakasiyana-siyana kuti vaone kuoma kwechirwere chacho. Chimwe chezvinhu izvi chiyero chinonzi spirometry , umo zviyero zvakasiyana zvemapapu zvinogona kuverengwa.
Kuyera FEV1 / FVC
Chimwe chiitiko chinokosha vanachiremba vanoshandisa kuongorora mapapu basa ndiro chiyero chekumanikidzirwa kuvhara muviri mune imwe yechipiri ( FEV1 ) pamusoro pekumanikidzirwa kukwanisa kubata ( FVC ), inozivikanwawo seTiffeneau-Pinelli index.
Ichi chiyero chehuwandu hwemhepo inoputirwa nesimba mune imwe yechipiri ichienzaniswa nehuwandu hwemhepo inogona kusunungurwa zvakasimba mukufema kwakakwana.
Uwandu hwemhepo yaunonyora mune imwe yechipiri yakanyorwa pamwe chete nehuwandu hwemhepo iwe unokwanisa kubudisa. Kubva pane nhamba yeFVC yakaverengwa yezera rako nehukuru, chiyero chezviyero zviviri izvi zvinozoongororwa. Kazhinji, maitiro maviri aya akaenzana. Kana iFVC iri kuderera, zvino chiyero chinotariswa zvakanyatsoitika.
Yakaderera FVC neProportional FEV1 / FVC Ratio-Restrictive Pattern
Kana FVC yako yakaderera asi chiyero che FEV1 / FVC chakasikwa, izvi zvinoratidza chikonzero chekudzivirira. Zvirwere zvinopfurikidza zvirwere zvemapapu zvinogona kunge zviri izvo mapapu emapapu pachake akaparara, kana kuti kuronga mumwe munhu asingakwanisi kufema zvakadzama sezvinoitika. Mimwe mienzaniso inosanganisira:
- Pulmonary fibrosis, yakadai se- idiopathic pulmonary fibrosis , kuora kwemapapu asina chikonzero.
- Kuipa kwechifuva chakadai sekoroliosis kana chifuva rusvingo rusvingo
- Kuvhiyiwa kwekenza yemaperembudzi, yakadai selobectomy kana pneumonectomy
- Zvirwere uye zvirwere zvinoputika zvakadai sepneumonia, tuberculosis, sarcoidosis, silicosis, uye asbestosis
- Neurological disorders yakadai seAAL
- Pleural effusion, iyo inoshandiswa mumvura pakati penharaunda inopoteredza mapapu
- Ascites, chivako chemvura mukati mechikonzero chechiropa chechiropa kana kenza mumudumbu chinogona kukonzera nzira yekudzivirira kuburikidza nekudzikisa kukwanisa kutora kufema kwakadzika.
Yakaderera FVC neAkaderedza FEV1 / FVC Ratio-Obstructive Pattern
Kana FVC yako yakaderera uye yako FEV1 / FVC chiyero ichidererawo, izvi zvinopesana nehupombwe hwemapapu emapapu seAphma neCOPD. Kazhinji, izvi zvinowanikwa kana FEV1 / FVC iri pasi kana kuti yakaenzana ne70 kusvika ku80 muzana yevanhu vakuru, uye 85 muzana muvana. Kukuvadza kune airway uye / kana kusimba kwemhepo inoyerera zvinoratidza zvinhu zvakadai se:
- Asthma
- Zvirwere zvisingagadziriswi zveplenmone zvirwere zvakadai sebronchitis isingaperi, emphysema, uye bronchiectasis
- Bronchiolitis
Zvitsva Zvitsva
Kana chikonzero chekuchengetedza chikaonekwa, vanachiremba vanowanzokurudzira zvizere zvepermonary work test kuti urambe uchiratidza mapapu ako. Kana nzira yekudzivirira inowanikwa, danho rinotevera rinowanzokurudzira kurapwa neBronchodilator , mushonga unobatsira kuderedza kushandiswa kwemhepo uye kudzoka zvakare.
Kana iwe uri kurapwa nokuda kwechirwere chinoparadza chirwere, chiremba wako angangotarisa kufambira mberi kwako achishandisa FEV1 / FVC chiyero chako. Kana chiyero ichi chakanatsika ne-bronchodilator, izvo zvinoreva kuti kuvhiringidzika kunenge kusinganzwisisiki "kuchinjwa." Izvi zvinoonekwa nemamiriro ezvinhu akafanana nehutema.
Kana uwandu hwacho husingafambi nehurumende, inogona kunge isingagadziriswi, yakadai seCOPD.
Sources:
> Godfrey, M., uye M. Jankowich. Kukosha Kwakakosha Kunokosha: Epidemiology uye Clinical Significance ye Restrictive Spirometry Pattern. Chest . 2016. 149 (1): 238-251.
Johnson, J., uye W. Theurer. Nzira Inofamba Nesimba kuKushandurwa Kwemashandiro Emapurmonary Test. American Family Physician . 2014. 89 (5): 359-366.
> Koo, K., Yun, H., Byeong-Ho, J. et al. Ukama Pakati Pezvakakosha Zvakakosha Zvokuita uye Framingham Mitsemisi Yengozi Kunze kweKuvapo kweMetabolic Syndrome: Yechina Korea Health and Nutrition Examination Survey. Medicine . 2015. 94 (47): e2089.